Oestrogen inhibition reverses pulmonary arterial hypertension and associated metabolic defects. [electronic resource]
Producer: 20180517ISSN:- 1399-3003
- Anastrozole
- Animals
- Bone Morphogenetic Protein Receptors, Type II -- genetics
- Disease Models, Animal
- Echocardiography
- Estradiol -- analogs & derivatives
- Estrogen Antagonists -- pharmacology
- Female
- Fulvestrant
- Hemodynamics
- Humans
- Hypertension, Pulmonary -- drug therapy
- Insulin Resistance
- Lung -- pathology
- Mice
- Mice, Knockout
- Mutation
- Nitriles -- pharmacology
- Signal Transduction -- drug effects
- Tamoxifen -- pharmacology
- Triazoles -- pharmacology
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.